These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8057103)

  • 21. 2',5'-Oligoadenylate and 2',5'-oligoadenylate phosphodiesterase in human plasma.
    Sawai H; Ishibashi K; Itoh M; Watanabe S
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1061-6. PubMed ID: 6517934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon (IFN)-alpha, beta, gamma].
    Uno K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():89-92. PubMed ID: 16149460
    [No Abstract]   [Full Text] [Related]  

  • 23. [Investigation of 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear leukocytes in Behçet's disease].
    Ohno S; Kotake S; Hirose S; Matsuda H; Fujii N
    Nippon Ganka Gakkai Zasshi; 1986 May; 90(5):771-4. PubMed ID: 2428227
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.
    Vojdani A; Lapp CW
    Immunopharmacol Immunotoxicol; 1999 May; 21(2):175-202. PubMed ID: 10319275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells from patients with fulminant hepatitis.
    Nishino S; Ohnishi H; Muto Y; Moriwaki H; Sakai T; Sugihara J; Saitoh K
    Gastroenterol Jpn; 1989 Jun; 24(3):337. PubMed ID: 2744346
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum 2-5 oligoadenylate synthetase activity in infectious diseases and collagen diseases in childhood].
    Arai T; Yamamoto H; Sakamoto M; Eda N; Matsumoto T; Ikei K; Hashimoto H; Seki T; Ohtani T; Ohishi T
    Kaku Igaku; 1991 Feb; 28(2):197-203. PubMed ID: 2051656
    [No Abstract]   [Full Text] [Related]  

  • 27. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
    Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
    Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
    Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
    Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
    [No Abstract]   [Full Text] [Related]  

  • 29. [Non-specific immune response in acute viral hepatitis: studies from serum 2,5-oligoadenylate synthetase activity and serum and histochemical changes in beta 2 microglobulin].
    Suzuki H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1508-17. PubMed ID: 3054207
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance of 2-5 oligoadenylate synthetase analysis in blood cell chemical analysis].
    Kato Y; Hattori N
    Nihon Rinsho; 1989 Dec; 48 Suppl():963-6. PubMed ID: 2482910
    [No Abstract]   [Full Text] [Related]  

  • 31. Relation of endogenous interferon and high levels of 2'-5' oligoadenylate synthetase in leukocytes from patients with Argentine hemorrhagic fever.
    Ferbus D; Saavedra MC; Levis S; Maiztegui J; Falcoff R
    J Infect Dis; 1988 May; 157(5):1061-4. PubMed ID: 3361147
    [No Abstract]   [Full Text] [Related]  

  • 32. [2' 5'-oligoadenylate synthetase (2-5AS)].
    Kaneko S; Sakai A
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():812-4. PubMed ID: 15658457
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.
    Sugino H; Mitani I; Koike M; Kodama T; Sokawa J; Sawai H; Ishibashi K; Itoh M; Watanabe S; Sokawa Y
    J Clin Microbiol; 1986 Sep; 24(3):478-81. PubMed ID: 3760142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting responses to interferon.
    Lancet; 1990 Dec; 336(8727):1388-9. PubMed ID: 1978206
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon and 2-5A synthetase in patients with immune diseases.
    Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
    Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
    [No Abstract]   [Full Text] [Related]  

  • 36. High level activity of 2', 5'-oligoadenylate synthetase in dog serum.
    Iwata A; Yamamoto A; Fujino M; Sato I; Hosokawa-Kanai T; Tuchiya K; Ishihama A; Sokawa Y
    J Vet Med Sci; 2004 Jun; 66(6):721-4. PubMed ID: 15240951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
    Buchwald D; Wener MH; Pearlman T; Kith P
    J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent elevation of 2-5A synthetase and prognosis in the AIDS-related complex (ARC).
    Read SE; LeBrocq FJ; Williams BR
    Prog Clin Biol Res; 1985; 202():405-13. PubMed ID: 3008172
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for the viral aetiology of IDDM.
    Petrovsky N; Harrison LC; Kyvik KO; Beck-Nielsen H; Green A; Bonnevie-Nielsen V
    Autoimmunity; 1997; 25(4):251-2. PubMed ID: 9344333
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioimmuno assay for 2-5 A using a novel 125I-labeled 2-5 A analog, and analysis of 2-5 A and 2-5 A synthetase activity in human plasma.
    Sawai H; Ishibashi K; Itoh M; Watanabe S
    Prog Clin Biol Res; 1985; 202():97-104. PubMed ID: 3832078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.